Phase
Condition
Memory Loss
Memory Problems
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
Ages 40-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All dry AMD patients were diagnosed based on the Clinical Classification ofAge-Related Macular Degeneration issued by the American Academy of Ophthalmology.
All patients with MCI meet the Petersen criteria, including memory impairment, no abnormal cognitive function, dementia, or some cognitive impairment in daily life. A Mini-Mental State Examination (MMSE) score ≥24 points and a Montreal Cognitive Assessment (MoCA) score between 18 and 25 points were required.
Exclusion
Exclusion Criteria:
- The systemic physical exclusion criteria were as follows:(a) Metabolic syndromessuch as diabetes or obesity;(b) Uncontrolled hypertension or hypotension;(c) Seriouscardiac disease;(d) Neurological diseases, including Parkinson's disease, multiplesclerosis, or peripheral neuropathy;(e) Psychiatric diseases such as hallucinationsor depressive disorders;(f) a history of brain injury, stroke, or substance abuse.
The ocular exclusion criteria were as follows: (a) intraocular pressure(IOP) > 21 mmHg; (b) axial length(AL) > 25 mm or <22 mm; (c) anterior segment disease affecting fundus examination; (d) retinal pathologic changes associated with high myopia or serious refractive errors (>5D of spherical equivalent refraction or >3D of astigmatism); (e) concomitant ocular diseases, such as glaucoma or retinal detachment; (f) other genetic ocular diseases; and (g) other fundus diseases, including macular hiatus, macular edema, retinal vascular occlusion, or central serous chorioretinopathy.
Study Design
Connect with a study center
Shanghai Tenth People's Hospital
Shanghai, Shanghai 200070
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.